24-Month results of the BRAVO study: A prospective, multi-center study evaluating the clinical outcomes of a ventral hernia cohort treated with OviTex® 1S permanent reinforced tissue matrix.

DeNoto, George; Ceppa, Eugene P; Pacella, Salvatore J; Sawyer, Michael; Slayden, Geoffrey; Takata, Mark; Tuma, Gary; Yunis, Jonathan

DeNoto, George; Ceppa, Eugene P; Pacella, Salvatore J; Sawyer, Michael; Slayden, Geoffrey; Takata, Mark; Tuma, Gary; Yunis, Jonathan.

Afiliação

DeNoto G; Department of General Surgery, St. Francis Hospital, Roslyn, NY, 11576, USA.
Ceppa EP; Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Pacella SJ; Scripps Clinic and Scripps M.D. Anderson Cancer Center, Division of Plastic and Reconstructive Surgery, San Diego, CA, 92130, USA.
Sawyer M; Department of Surgery, Comanche County Memorial Hospital, Lawton, OK, 73505, USA.
Slayden G; St. Luke's Surgical Specialists, St. Luke's Health System, Overland Park, KS, 66213, USA.
Takata M; Scripps Clinic Medical Group, Department of Surgery, La Jolla, CA, 92037, USA.
Tuma G; Capital Health Medical Group, Department of Plastic Surgery, Pennington, NJ, 08534, USA.
Yunis J; Hernia Specialist, Center for Hernia Repair, Sarasota, FL, 34239, USA.

Ann Med Surg (Lond) ; 83: 104745, 2022 Nov.

Article em En | MEDLINE | ID: mdl-36389188

Palavras-chave

Hernia recurrence; Ovine reinforced tissue matrix; Reinforced biologic; Ventral hernia repair

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google